Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Mar. 26, 2026 Deepfake X-rays created by AI are now convincing enough to fool both doctors and AI models. In tests, radiologists had limited success identifying fake images, especially when they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results